Abstract:Protein-targeted degradation is an emerging and promising therapeutic approach. The specificity of degradation and the maintenance of cellular homeostasis are determined by the interactions between E3 ubiquitin ligase and degradation signals, known as degrons. The human genome encodes over 600 E3 ligases; however, only a small number of targeted degron instances have been identified so far. In this study, we introduced DegronMD, an open knowledgebase designed for the investigation of degrons, their associated dysfunctional events, and drug responses. We revealed that degrons are evolutionarily conserved and tend to occur near the sites of protein translational modifications, particularly in the regions of disordered structure and higher solvent accessibility. Through pattern recognition and machine learning techniques, we constructed the degrome landscape across the human proteome, yielding over 18,000 new degrons for targeted protein degradation. Furthermore, dysfunction of degrons disrupts the degradation process and leads to the abnormal accumulation of proteins; this process is associated with various types of human cancers. Based on the estimated phenotypic changes induced by somatic mutations, we systematically quantified and assessed the impact of mutations on degron function in pan-cancers; these results helped to build a global mutational map on human degrome, including 89,318 actionable mutations that may induce the dysfunction of degrons and disrupt protein degradation pathways. Multiomics integrative analysis unveiled over 400 drug resistance events associated with the mutations in functional degrons. DegronMD, accessible at https://bioinfo.uth.edu/degronmd, is a useful resource to explore the biological mechanisms, infer protein degradation, and assist with drug discovery and design on degrons.

The C‐degron pathway eliminates mislocalized proteins and products of deubiquitinating enzymes

N-degron and C-degron pathways of protein degradation

Protein degrons and degradation: Exploring substrate recognition and pathway selection in plants

N-degron pathways

Identification of New Degrons in Streptococcus Mutans Reveals a Novel Strategy for Engineering Targeted, Controllable Proteolysis.

CRL2ZER1/ZYG11B Recognizes Small N-terminal Residues for Degradation

Targeted protein degradation: from small molecules to complex organelles—a Keystone Symposia report

Monitoring the interactions between N-degrons and N-recognins of the Arg/N-degron pathway

HSP70-binding motifs function as protein quality control degrons

CRL2 ZER1/ZYG11B recognizes small N-terminal residues for degradation

Regulation of Neurodegeneration-associated Protein Fragments by the N-degron Pathways

DegronMD: Leveraging Evolutionary and Structural Features for Deciphering Protein-Targeted Degradation, Mutations, and Drug Response to Degrons

A cellular assay system revealed the deamidase-mediated regulation of the Arg-mediated N-end rule protein degradation pathway

C-terminal glutamine acts as a C-degron targeted by E3 ubiquitin ligase TRIM7

Molecular Basis for C-degron Recognition by CRL2APPBP2 Ubiquitin Ligase.

Localized Proteasomal Degradation: From the Nucleus to Cell Periphery

Degron capability of the hydrophobic C‐terminus of the polyglutamine disease protein, ataxin‐3

Investigating the p21 Ubiquitin-Independent Degron Reveals a Dual Degron Module Regulating p21 Degradation and Function.

Investigating the p21 Ubiquitin-Independent Degron Reveals a Dual Degron Module Regulating p21 Degradation and Function

Identification of ERAD-dependent degrons for the endoplasmic reticulum lumen.

UBR4 regulates a MetAP2-dependent Arg/N-degron pathway